COR-1004 / Corsera Health - LARVOL DELTA

A Study to Evaluate COR-2003 as Monotherapy and Co-Administered With COR-1004 in Adult Volunteers (clinicaltrials.gov) - P1 | N=108 | Not yet recruiting | Sponsor: Corsera Health

Monotherapy • New P1 trial • Dyslipidemia

COR-PCS-25-101: A Study to Evaluate COR-1004 in Adult Volunteers. (clinicaltrials.gov) - P1 | N=60 | Active, not recruiting | Sponsor: Corsera Health | Recruiting ➔ Active, not recruiting | Trial primary completion date: Jul 2026 ➔ Oct 2026

Enrollment closed • Trial primary completion date • Dyslipidemia

COR-PCS-25-101: A Study to Evaluate COR-1004 in Adult Volunteers. (clinicaltrials.gov) - P1 | N=60 | Recruiting | Sponsor: Corsera Health | Not yet recruiting ➔ Recruiting

Enrollment open • Dyslipidemia

COR-PCS-25-101: A Study to Evaluate COR-1004 in Adult Volunteers. (clinicaltrials.gov) - P1 | N=60 | Not yet recruiting | Sponsor: Corsera Health

New P1 trial • Dyslipidemia